UK Markets open in 4 hrs 27 mins

PharmaEngine, Inc. (4162.TWO)


Taiwan OTC - Taiwan OTC Delayed price. Currency in TWD
Add to watchlist
221.50-2.50 (-1.12%)
As of 10:11AM CST. Market open.
Full screen
Previous close224.00
Open226.50
Bid221.50 x
Ask222.50 x
Day's range220.00 - 227.00
52-week range174.00 - 255.00
Volume1,486,000
Avg. volume500,384
Market cap27.01B
BetaN/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Reuters2 years ago

    FDA clears Merrimack's pancreatic cancer drug with warning

    The U.S. Food and Drug Administration approved Merrimack Pharmaceutical Inc's pancreatic cancer therapy Onivyde, but with a serious warning, marking the company's first ever drug to win regulatory clearance. The drug in combination with chemotherapy treatments 5-fluorouracil and leucovorin treats metastatic pancreatic cancer in patients, who have failed to respond to chemotherapy drug gemcitabine. Onivyde, however, carries a black box warning about severe risks of diarrhea and low white blood cell count, the agency said, adding that it was not approved for use as a single agent.

  • Reuters2 years ago

    Merrimack Pharma's cancer drug wins FDA approval

    The U.S. Food and Drug Administration approved Merrimack Pharmaceutical Inc's pancreatic cancer therapy, Onivyde, making it the company's first approved drug. Onivyde, when used in combination with chemotherapy ...

  • We're sorry, but this is all we were able to find on this topic.